OTC Markets OTCQB - Delayed Quote • USD NIKA PHARMACEUTICALS INC. (NIKA) Follow Compare 0.5900 0.0000 (0.00%) At close: January 8 at 9:54:12 AM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Nika Pharmaceuticals, Inc. (NIKA) Signed a Distribution Agreement for Nigeria HENDERSON, Nev., July 18, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) announces the signing of a distribution agreement for the Republic of Nigeria. The extensive negotiations with I.Conntact-Connect Limited finalized on June 11, 2024 and will allow NIKA to have a strong partner in a key market of 229 million people where recent estimates report a 2.1% national HIV prevalence (approximately 2 million people)1. Under the agreement’s terms, NIKA will receive €1,980 per each Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy HENDERSON, Nev., June 03, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) introduces its plans to develop the company into a sustainable business project that will consistently grow, bring good profits and provide dividends to its shareholders. To achieve its goals, NIKA will work towards the construction of three pharmaceutical facilities: A factory for the production of drugs in injection formA factory for the production of drugs in tablet formA factory for the production o Nika Pharmaceuticals, Inc. (NIKA) Acquires a Two Million USD Production Building HENDERSON, Nev., May 10, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) announces that it is the beneficial owner of a production building and land valued at $2,045,209, located in Sofia Province, Bulgaria. On May 9, 2024, NIKA acquired Nika Pharmaceuticals, Ltd.; as a result, the company became 99.99% owner of Nika Europe, Ltd, in whose capital the production building and land were previously contributed in-kind on April 29 after an extensive valuation by three independent Performance Overview Trailing total returns as of 1/8/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return NIKA S&P 500 YTD +16.32% +0.19% 1-Year -95.78% +25.99% 3-Year -95.78% +26.54%